Introduction: The CRISPR Diagnostics Revolution
Since the discovery of Cas12a (Cpf1) collateral cleavage activity, molecular diagnostics has shifted from lab-bound PCR to field-deployable DETECTR and HOLMES assays. This comprehensive guide covers everything you need to know about setting up a high-sensitivity CRISPR-Cas12a lateral flow system.
Chapter 1: Mechanism of Action
Unlike Cas9, which targets DNA for cutting, Cas12a possesses indiscriminate single-stranded DNA (ssDNA) cleavage activity upon target binding. This “trans-cleavage” is the engine of the diagnostic signal. When a FAM-Biotin reporter is cleaved, the separation allows the FAM molecule to bind at the Test line.
Chapter 2: Designing crRNAs and Primers
Target selection is critical. We recommend targeting conserved regions (e.g., N-gene for SARS-CoV-2, p72 for ASFV). RPA primers should be 30-35bp long. For crRNA, a 20-24nt spacer is optimal. (See our Cas12a Product Page for sequences).
Chapter 3: The Lateral Flow Readout
Not all strips work. You need a “Low-Noise” membrane. Standard membranes often bind the uncleaved reporter, causing a false positive C-line depletion or high background. Tiosbio® Universal Strips are treated with a blocking buffer specifically to prevent ssDNA adsorption.
Chapter 4: Optimization & Troubleshooting
| Problem | Cause | Solution |
|---|---|---|
| False Positive | Reporter degradation (DNase) | Add RNase/DNase inhibitors; use Nuclease-free water. |
| Weak Signal | Low enzyme activity | Switch to high-purity LwaCas13a; optimize Mg2+ concentration. |
| Ghost Lines | Conjugate aggregation | Use high-surfactant running buffer (e.g., 1% Tween-20). |
Conclusion
Mastering CRISPR diagnostics requires harmonizing the enzyme, the chemistry, and the lateral flow strip. Due Bio provides the complete ecosystem to take your assay from concept to clinic.